Trial Outcomes & Findings for The ACTIVE Intervention to Improve Hospice Care (NCT NCT01211340)
NCT ID: NCT01211340
Last Updated: 2021-02-04
Results Overview
This 16 question instrument measures the perceptions hospice caregivers have toward the administration of pain medications. Scores on items vary from 1-5 with the lower scores indicating more problematic perceptions of pain management. A Total score is computed between 16-80 Only the last available measure will be used to reflect the measure closest to time of death.
COMPLETED
NA
446 participants
Every 14 days until the death of the patient for an average of 45 days-Only measure used in analysis is the last completed measure
2021-02-04
Participant Flow
Participant milestones
| Measure |
Usual Care
This arm serves as the control, individuals will not receive the intervention but will receive all measures
|
Intervention Arm
These caregivers will receive usual care plus the technology which allows them to participate in their plan of care meeting
ACTIVE: Assessing Caregivers for Team Intervention via Video Encounters: this intervention uses video technology to bridge geographic distance to empower hospice caregivers to participate in plan of care meetings for their patient
|
|---|---|---|
|
Overall Study
STARTED
|
223
|
223
|
|
Overall Study
COMPLETED
|
223
|
223
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
The ACTIVE Intervention to Improve Hospice Care
Baseline characteristics by cohort
| Measure |
Usual Care
n=223 Participants
This arm serves as the control, individuals will not receive the intervention but will receive all measures
|
Intervention Arm
n=223 Participants
These caregivers will receive usual care plus the technology which allows them to participate in their plan of care meeting
ACTIVE: Assessing Caregivers for Team Intervention via Video Encounters: this intervention uses video technology to bridge geographic distance to empower hospice caregivers to participate in plan of care meetings for their patient
|
Total
n=446 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
59.2 years
STANDARD_DEVIATION 13.3 • n=5 Participants
|
60.1 years
STANDARD_DEVIATION 12.5 • n=7 Participants
|
59.7 years
STANDARD_DEVIATION 12.9 • n=5 Participants
|
|
Sex: Female, Male
Female
|
182 Participants
n=5 Participants
|
168 Participants
n=7 Participants
|
350 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
41 Participants
n=5 Participants
|
55 Participants
n=7 Participants
|
96 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
5 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
221 Participants
n=5 Participants
|
220 Participants
n=7 Participants
|
441 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
2 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
13 Participants
n=5 Participants
|
10 Participants
n=7 Participants
|
23 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
205 Participants
n=5 Participants
|
204 Participants
n=7 Participants
|
409 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
223 participants
n=5 Participants
|
223 participants
n=7 Participants
|
446 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Every 14 days until the death of the patient for an average of 45 days-Only measure used in analysis is the last completed measureThis 16 question instrument measures the perceptions hospice caregivers have toward the administration of pain medications. Scores on items vary from 1-5 with the lower scores indicating more problematic perceptions of pain management. A Total score is computed between 16-80 Only the last available measure will be used to reflect the measure closest to time of death.
Outcome measures
| Measure |
Usual Care
n=223 Participants
This arm serves as the control, individuals will not receive the intervention but will receive all measures
|
Intervention Arm
n=223 Participants
These caregivers will receive usual care plus the technology which allows them to participate in their plan of care meeting
ACTIVE: Assessing Caregivers for Team Intervention via Video Encounters: this intervention uses video technology to bridge geographic distance to empower hospice caregivers to participate in plan of care meetings for their patient
|
|---|---|---|
|
Caregiver Perceptions of Pain Medicine Questionaire
Baseline
|
49.6 units on a scale
Standard Deviation 7.3
|
49 units on a scale
Standard Deviation 7.43
|
|
Caregiver Perceptions of Pain Medicine Questionaire
Last Measure
|
50.3 units on a scale
Standard Deviation 7.12
|
50.5 units on a scale
Standard Deviation 7.33
|
SECONDARY outcome
Timeframe: Every 14 days until the death of the patient for an average of 45 days-Only measure used in analysis is the last completed measureThis is one domain of a four domain instrument. It involves one question with a range of 0-10.Only the last available measure will be used to reflect the measure closest to time of death.
Outcome measures
| Measure |
Usual Care
n=223 Participants
This arm serves as the control, individuals will not receive the intervention but will receive all measures
|
Intervention Arm
n=223 Participants
These caregivers will receive usual care plus the technology which allows them to participate in their plan of care meeting
ACTIVE: Assessing Caregivers for Team Intervention via Video Encounters: this intervention uses video technology to bridge geographic distance to empower hospice caregivers to participate in plan of care meetings for their patient
|
|---|---|---|
|
Caregiver Quality of Life-Revised Subscale Emotional
Baseline
|
7.06 units on a scale
Standard Deviation 2.26
|
7.61 units on a scale
Standard Deviation 1.93
|
|
Caregiver Quality of Life-Revised Subscale Emotional
Last Measure
|
6.95 units on a scale
Standard Deviation 2.08
|
7.19 units on a scale
Standard Deviation 2.03
|
SECONDARY outcome
Timeframe: Every 14 days until the death of the patient for an average of 45 days-Only measure used in analysis is the last completed measureThis measure determines the level of anxiety experienced by a hospice caregiver. Total scores range from 0-21 with higher scores representing more anxiety. Only the last available measure will be used to reflect the measure closest to time of death.
Outcome measures
| Measure |
Usual Care
n=223 Participants
This arm serves as the control, individuals will not receive the intervention but will receive all measures
|
Intervention Arm
n=223 Participants
These caregivers will receive usual care plus the technology which allows them to participate in their plan of care meeting
ACTIVE: Assessing Caregivers for Team Intervention via Video Encounters: this intervention uses video technology to bridge geographic distance to empower hospice caregivers to participate in plan of care meetings for their patient
|
|---|---|---|
|
Anxiety
Baseline
|
6.65 units on a scale
Standard Deviation 5.33
|
5.86 units on a scale
Standard Deviation 5.16
|
|
Anxiety
Last Measure
|
6.37 units on a scale
Standard Deviation 5.81
|
5.86 units on a scale
Standard Deviation 5.16
|
Adverse Events
Usual Care
Intervention Arm
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place